Fusidic acid in vitro activity

International Journal of Antimicrobial Agents

Volumn 12, Issue SUPPL. 2, 1999, Pages

  Collignon, Peter ^a   Turnidge, John ^b  

^a CANBERRA HOSPITAL   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Fusidic acid; Inoculum effect; Neutrophils; T lymphocytes

Indexed keywords

AMINOGLYCOSIDE; CEPHALOSPORIN; CHLOROQUINE; ELONGATION FACTOR G; FOSFOMYCIN; FUSIDIC ACID; MACROLIDE; NOVOBIOCIN; QUININE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ANTIMICROBIAL ACTIVITY; BORDETELLA PERTUSSIS; DRUG ACTIVITY; DRUG MECHANISM; ENTEROCOCCUS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM; NEISSERIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS;

EID: 0032839415     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(98)00073-9     Document Type: Article

References (105)

1. Verbist L. The antimicrobial activity of fusidic acid, J Antimicrob Chemother 1990;25 Suppl B:1-5.
2. von Daehne W, Godtfredsen WO, Rasmussen PR Structure-activity relationships in fusidic acid-type antibiotics. Adv Appl Microbiol. 25:1979;95-146.
3. von der Haar B, Schrempf H Purification and characterization of a novel extracellular Streptomyces lividans 66 enzyme inactivating fusidic acid. J Bacteriol. 177:1995;152-155.
4. Perry MJ, Hendricks-Gittins A, Stacey LM, Adlard MW, Noble WC Fusidane antibiotics produced by dermatophytes. J Antibiot (Tokyo). 36:1983;1659-1663.
5. Tanaka N, Kinoshita T, Masukawa H Mechanism of protein synthesis inhibition by fusidic acid and related antibiotics. Biochem Biophys Res Commun. 15:1968;278-283.
6. Cundliffe E The mode of action of fusidic acid. Biochem Biophys Res Commun. 46:1972;1794-1801.
7. Yaskowiak ES, March PE Small clusters of divergent amino acids surrounding the effector domain mediate the varied phenotypes of EF-G and LepA expression. Mol Microbiol. 15:1995;943-953.
8. Mazumder R Sites of action of fusidic acid in eukaryotes; inhibition by fusidic acid of a ribosome-independent GTPase from Artemia salina embryos. Eur J Biochem. 58:1975;549-554.
9. Ching HK, Spremulli VT Purification and characterization of elongation factor G from bovine liver mitochondria. J Biol Chem. 265:1990;21000-21004.
10. Otaka T, Kaji A Evidence that fusidic acid inhibits the binding of aminoacyl-tRNA to the donor as well as the acceptor site of the ribosomes. Eur J Biochem. 38:1973;46-53.
11. Godtfredsen WO, Von Daehne W, Tybring L, Vangedal S Fusidic acid derivatives I: relationships between structure and antibacterial activity. J Med Chem. 9:1966;15-22.
12. Willie GR, Richman N, Godtfredsen WP, Bodley JW Some characteristics of and structural requirements for the interaction of 24,25-dihydrofusidic acid with ribosome-elongation factor G complexes. Biochemistry. 14:1975;1713-1718.
13. von Daehne W, Godtfredsen WO, Rasmussen PR Structure-activity relationships in fusidic acid-type antibiotics. Adv Appl Microbiol. 25:1979;95-146.
14. Greenwood D, O'Grady F Scanning electron microscopy of Staphylococcus aureus exposed to some common anti-staphylococcal agents. J Gen Microbiol. 70:1972;263-270.
15. Røder BL, Forsgren A, Gutschik E The effect of antistaphylococcal agents used alone and in combinations on the survival of Staphylococcus aureus ingested by human polymorphonuclear leukocytes. APMIS. 99:1991;521-529.
16. Huebner J, Kropec A, Engels I, Daschner F In vitro susceptibility of methicillin-resistant Staphylococcus aureus and slime-producing and non-slime-producing coagulase-negative staphylococci to fusidic acid. Chemotherapy. 38:1992;206-210.
17. Faber M, Rosdahl VT. Susceptibility to fusidic acid among Danish Staphylococcus aureus strains and fusidic acid consumption, J Antimicrob Chemother 1990;25 Suppl B:7-14.
18. Robbins M, Marais R, Wilson AP, Felmingham D Activity of sodium fusidate in vitro against anaerobic bacteria (letter). Eur J Clin Microbiol. 6:1987;326-327.
19. Evans RJ, Waterworth PM Naturally-occurring fusidic acid resistance in staphylococci and its linkage to other resistances. J Clin Pathol. 19:1966;555-560.
20. George RH The influence of protein binding on the antistaphylococcal activity of antibiotics. J Antimicrob Chemother. 17:1986;539-546.
21. Coutant C, Olden D, Bell J, Turnidge JD Disk diffusion interpretive criteria for fusidic acid susceptibility testing of staphylococci by the NCCLS method. Diagn Microbiol Infect Dis. 25:1996;9-13.
22. Turnidge JD, Nimmo GR, Francis G Evolution of resistance in Staphylococcus aureus in Australian teaching hospitals. Med J Aust. 164:1996;68-71.
23. Traub WH, Kleber I Interpretation of diffusion susceptibility data obtained with 10 μg Fucidin (sodium fusidate) disks against clinical isolates of Staphylococcus aureus. Chemotherapy (Basel). 20:1974;92-96.
24. Richardson JF, Marples RR Differences in antibiotic susceptibility between Staphylococcus epidermidis and Staphylococcus saprophyticus. J Antimicrob Chemother. 6:1980;499-510.
25. Larsson PG, Melby K Antibiotic susceptibility pattern of community strains of the genus staphylococcus with special reference to S. saprophyticus. NIPH Ann. 4:1981;61-68.
26. Toma E, Barriault D Antimicrobial activity of fusidic acid and disk diffusion susceptibility testing criteria for Gram-positive cocci. J Clin Microbiol. 33:1995;1712-1715.
27. Barber M, Waterworth PM Antibacterial activity in vitro of Fucidin. Lancet. 1:1962;931-932.
28. Rymkiewicz D Effect of some antibiotics; disinfectants; and UV light on viability of vegetative cells and spores of Cl perfringens type A. Med Dosw Mikrobiol. 29:1977;263-269.
29. Taylor G, Bloor K Antistaphylococcal activity of Fucidin. Lancet. 1:1962;935-937.
30. Jedlickova VZ Contribution to the study of the sensitivity of staphylococci toward so-called anti-staphylococcal antibiotics. Arzneimittelforschung. 17:1967;706-709.
31. Jeljaszewicz J, Pulverer G Geographical differences in antibiotic sensitivity patterns: comparison of staphylococci in Poland and Germany. Med Microbiol Immunol (Berlin). 158:1973;177-183.
32. Barry AL, Thornsberry C, Jones RN Evaluation of teicoplanin and vancomycin disk susceptibility tests. J Clin Microbiol. 23:1986;100-103.
33. Kanazaki H, Akiyama H, Kanamoto A, Abe Y, Yamada T, Arata J, Umemura S, Ikeda M Outbreak of fusidic acid resistant Staphylococcus aureus. Nippon Hifuka Gakkai Zasshi. 99:1989;507-510.
34. Barry AL, Jones RN In vitro activity of ciprofloxacin against Gram-positive cocci. Am J Med. 82(Suppl 4):1987;27-32.
35. Jones RN, Barry AL Antimicrobial activity of coumermycin and recommendations for disk diffusion tests with 5 and 15 μg disks. Diagn Microbiol Infect Dis. 7:1987;77-82.
36. Pohlod DJ, Saravolatz LD, Somerville MM In-vitro susceptibility of Gram-positive cocci to LY146032 teicoplanin; sodium fusidate; vancomycin; and rifampicin. J Antimicrob Chemother. 20:1987;197-202.
37. Shibl AM, Ishag AH, Durgham SM. Antistaphylococcal activity of teicoplanin in Riyadh; Saudi Arabia, APMIS 1988;96 Suppl 3:68-70.
38. Drugeon HB, Caillon J, Juvin ME In vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus. J Antimicrob Chemother. 34:1994;899-907.
39. Chokkavelu V, Chandrasekar P, Rolston K, LeFrock JL, Schell RF Activity of eleven antimicrobial agents against methicillin-, methicillin- and rifampin-resistant Staphylococcus aureus. Chemotherapy. 30:1984;97-101.
40. Graninger W, Leitha T, Breyer S, Francesconi M, Lenz K, Georgopoulos A Methicillin- and gentamicin-resistant Staphylococcus aureus: suscetpibility to fosfomycin, cefamandole; N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin. Drugs Exp Clin Res. 11:1985;23-27.
41. Moorhouse EC, Mulvihill TE, Jones L, Mooney D, Falkiner FR, Keane CT The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 15:1985;291-295.
42. Dixson S, Brunfitt W, Hamilton-Miller JM In vitro activity of six antibiotics against multiresistant staphylococci and other Gram-positive cocci. Eur J Clin Microbiol. 4:1985;19-23.
43. Unowsky J, Chndrasekar PH, DeLorenzo W, Levine DP In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus. Chemotherapy. 32:1986;499-505.
44. Ishag AJ, Durgham SM, Shibl AM In vitro susceptibility of methicillin-resisatnt Staphylococcus aureus to imipenem and other antimicrobial agents. Chemiotherapia. 6:1987;261-263.
45. Maple PAC, Hamilton-Miller JMT, Brunfitt W World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Lancet. 1:1989;537-540.
46. Fosse T, Appert A, Delpech D, Laffont C In vitro activity of fusidic acid in combination with various antibiotics against Staphylococcus epidermidis. Pathol Biol (Paris). 36:1988;621-625.
47. Hart AP, McColl K, Thomas C, Orr NA Performance profiles of topical antimicrobials in vitro. J Appl Bacteriol. 67:1989;317-327.
48. Jeljaszewicz J, Stochmal I, Switalski LM, Pulverer G Susceptibility of viridans streptococci to 27 antimicrobial agents. Zbl Bakt Hyg I Abt Orig A. 236:1976;235-244.
49. Kidson A A new selective medium for Streptococcus pyogenes and other streptococci. J Med Lab Technol. 24:1967;179-186.
50. Jeljaszewicz J, Stochmal I, Pulverer G et al. Susceptibility of Streptococcus faecalis to 32 antimicrobial agents: comparison of patterns in Poland and Federal Republic of Germany. Zbl Bakt Hyg I Abt Orig A. 235:1976;386-398.
51. Traub WH, Spohr M, Bauer D Streptococcus faecalis: in vitro susceptibility to antimicrobial drugs; single and combined; with and without defibrinated human blood. Chemotherapy. 32:1986;270-285.
52. Freeman C, Robinson A, Cooper B, Mazens-Sullivan M, Quintiliani R, Nightingale C In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci. Diagn Microbiol Infect Dis. 21:1995;47-50.
53. Kobayashi M, Yamamoto S, Takami H, Mihara K Sensitivity test of clinical isolates to fusidic acid. Jpn J Antibiot. 24:1971;152-155.
54. Heczko PB, Kasprowicz A, Pulverer G Susceptibility of human skin aerobic diphtheroids to antimicrobial agents in vitro. J Antimicrob Chemother. 3:1977;141-146.
55. Veselov Aya Microflora of purulent inflammatory foci in surgical patients and its antibiotic sensitivity. Antibiotiki I Khimioterapiia. 35:1990;40-43.
56. Black WA, McNellis DA Susceptibility of Nocardia species to modern antimicrobial agents. Antimicrob Agents Chemother. 10:1970;346-349.
57. Goodfellow M, Orchard VA Antibiotic sensitivity of some nocardioform bacteria and its value as a criterion for taxonomy. J Gen Microbiol. 83:1974;375-387.
58. Nasher MA, Hay RJ, Mahgoub ES, Gumaa SA In vitro studies of antibiotic sensitivities of Streptomyces somaliensis - a cause of human actinomycetoma. Trans R Soc Trop Med Hyg. 83:1989;265-268.
59. Sims W Use of fusidic acid for differentiating homfermentative from heterofermentative lactobacilli. J Dent Res. 47:1968;105-107.
60. Bannatyne R.M., Cheung R. Antimicrobial susceptibility of Bordetella pertussis strains isolated from to 1981. Antimicrob. Agents Chemother. ; 21. 1982:1960;666-667.
61. Reyn A, Benzon MW A study of the relationships between the sensitivities of Neisseria gonorrhoeae to sodium penicillin G; four semi-synthetic penicillins; spiramycin; and fusidic acid. Br J Vener Dis. 44:1968;1450-1450.
62. Miles RS, Moyes A Comparison of susceptibility of Neisseria meningitidis to sodium sulphadiazine and sodium fusidate in vitro. J Clin Pathol. 31:1978;355-358.
63. Friis-Moller A, Rechnitzer C, Nielsen L, Madsen S Treatment of Legionella lung abscess with erythromycin and fusidic acid (letter). Eur J Clin Microbiol. 4:1985;513-515.
64. Van Caekenberghe D Comparative in vitro activities of ten fluoroquinolones and fusidic acid against Mycobacterium spp. J Antimicrob Chemother. 26:1990;381-386.
65. Hoffner SE, Olsson-Liljequist B, Rydgard KJ, Svenson SB, Kallenius G Susceptibility of mycobacteria to fusidic acid. Eur J Clin Microbiol Infect Dis. 9:1990;294-297.
66. Witzig RS, Franzblau SG Susceptibility of Mycobacterium kansasii to ofloxacin, sparfloxacin, clarithromycin, azithromycin and fusidic acid. Antimicrobial Agents Chemother. 37:1993;1997-1999.
67. Franzblau SG, Biswas AN, Harris EB Fusidic acid is highly active against extracellular and intracellular Mycobacterium leprae. Antimicrob Agents Chemother. 36:1992;92-94.
68. Godtfredsen W, Roholt K, Tybring L Fucidin; a new orally active antibiotic. Lancet. 1:1962;928-931.
69. Simon C, Littschwager G In vitro activity of ceftazidime in combination with other antibiotics. Infection. 13:1985;184-189.
70. Hassan H, O'Hare MD, Felmingham D In vitro activity of teicoplanin, vancomycin, A16686, clindamycin, erythromycin and fusidic acid against anaerobic bacteria. Singapore Med J. 31:1990;56-58.
71. Steinkraus GE, McCarthy LR In vitro activity of sodium fusidate against anaerobic bacteria. Antimicrob Agents Chemother. 16:1979;120-122.
72. Stirling J, Goodwin S Susceptibility of Bacteroides fragilis to fusidic acid. J Antimicrob Chemother. 3:1977;522-523.
73. Robb.
74. Canzi AM, Weber P, Boussougant Y Activity of fusidic acid on strictly anaerobic bacteria. Pathol Biol (Paris). 35:1987;577-580.
75. Aronsson B, Mölby R, Nord CE. Diagnosis and epidemiology of Clostridium difficile enterocolitis in Sweden, J Antimicrob Chemother 1984;14 Suppl D:85-95.
76. Nord CE, Lindmark A, Persson I Susceptibility of Clostridium difficile to LY146032. Eur J Clin Microbiol. 6:1987;189.
77. Spiekermann C In vitro sensitivity of Actinomyces israelii, Actinobacillus actinomycetem-comitans and Bacteroides melaninogenicus to cephalothin, cephaloridine, gentamicin, fusidic acid and licomycin. Int Z Klin Pharmakol Ther Toxikol. 3:1970;318-320.
78. Black FT, Wildfang IL, Borgbjerg K Activity of fusidic acid against Plasmodium falciparum in vitro (letter). Lancet. 1:1985;578-579.
79. Farthing MJ, Inge PM Antigiardial activity of the bile salt-like antibiotic sodium fusidate. J Antimicrob Chemother. 17:1986;165-171.
80. Inge PM, Farthing MJ A radiometric assay for antigiardial drugs. Trans R Soc Trop Med Hyg. 81:1987;345-347.
81. Redmann U Effect of several water-soluble steroids on the growth of Mycoplasma gallisepticum. Ann Inst Pasteur (Paris). 114:1968;313-315.
82. Torres H, Raoult D In vitro activities of ceftriaxone and fusidic acid against 13 isolates of Coxiella burnetii, determined using the shell vial assay. Antimicrob Agents Chemother. 37:1993;491-494.
83. Maehlen T, Degré M Lack of activity of fusidic acid against human immunodeficiency virus in monocytes. Antimicrob Agents Chemother. 33:1989;680-683.
84. O'Grady F, Greenwood D Interactions between fusidic acid and penicillins. J Med Microbiol. 6:1973;441-450.
85. Simon VC, Simon M Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters. Scand J Infect Dis. Suppl 72:1990;14-19.
86. Mouton RP, Koelman A The interaction patterns of combined antibacterial agents; experiments with two agar diffusion methods. Chemotherapy. 11:1966;10-26.
87. Raab W, Windisch J The effect of hydrocortisone, a steroid hormone, on the antibacterial activity of fusidic acid, a steroid antibiotic. Pathol Microbiol (Basel). 34:1969;52-59.
88. Jakubicz P, Jakoniuk P Studies on the combined action of Fucidin and β-lactam antibiotics on staphylococci. Arch Immunol Ther Exp (Wars). 19:1971;205-209.
89. Kenward MA, Alcock SR, McKay IC Effect of hyperbaric oxyhelium gas on response of bacteria to antimicrobial agents in vitro. Antimicrob Agents Chemother. 26:1984;833-836.
90. Roder BL, Gutschik E In vitro activity of ciprofloxacin combined with either fusidic acid or rifampicin against Staphylococcus aureus. J Antimicrob Chemother. 23:1989;347-352.
91. Foldes M, Munro R, Sorrell TC, Shanker S, Toohey M In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 11:1983;21-26.
92. Farber BF, Yee YC, Karchmer AW Interaction between rifampin and fusidic acid against methicillin-resistant caogulase-positive and -negative staphylococci. Antimicrob Agents Chemother. 30:1986;174-175.
93. Fantin B, Leclercq R, Duval J, Carbon C. Fusidic acid alone and in combination with vancomycin for therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureus, Antimicrob Agents Chemother 1993;2466-2469.
94. Uri JV Antibacterial antagonism between fusidic acid and ciprofloxacin. Acta Microbiol Hung. 40:1993;141-149.
95. Dixon RA, Chopra I Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapepeptide. Antimicrob Agents Chemother. 29:1986;781-788.
96. Vaara M, Jaakola J Sodium hexametaphosphate sensitizes Pseudomonas aeruginosa, several other species of Pseudomonas; and Escherichia coli to hydrophobic drugs. Antimicrob Agents Chemother. 33:1989;1741-1747.
97. Garrett ER, Richards AJ Kinetics and mechanisms of drug action on microorganisms XX: integrated receptor site model rationalizing observed microbial rate dependencies on drug concentration and microbial kinetics affected by sodium fusidate. J Pharm Sci. 63:1974;884-894.
98. Forsgren A, Schemling D Effect of antibiotics on chemotaxis of human leucocytes. Antimicrob Agents Chemother. 11:1977;580-584.
99. Forsgren A, Schemling D, Banck G. Effects of antibiotics on chemotaxis of human polymorphonuclear leucocytes in vitro, Infection 1978;6 Suppl 1:102-6.
100. Næss A, Flø RW, Solberg CO Effect of fusidic acid in migration and chemiluminescence of polymorphonuclear leukocytes. Eur J Clin Microbiol Infect Dis. 1:1990;42-44.
101. Forsgren A, Banck G. Influence of antibiotics on lymphocyte function in vitro, Infection 1978;6 Suppl 1:91-7.
102. Nielsen H Antibiotics and human monocyte function. Acta Path Microbiol Immunol Scand Sect B. 95:1987;293-296.
103. Gemmel CG, O'Dowd A Regulation of protein A biosynthesis in Staphylococcus aureus by certain antibiotics: its effect on phagocytosis by leukocytes. J Antimicrob Chemother. 12:1983;587-597.
104. Drugeon HB, Carpentier E Mechanisms of colonisation of biomaterials by staphylococci: influence of fusidic acid. Path Biol. 41:1993;392-398.
105. Speranskaia ON, Fomina TP, Kuznetsova SM Methicillin-resistant staphylococci: biological properties and sensitivities to antibiotics. Antibiotiki. 18:1973;62-68.